Catherine M Bollard Selected Research

Catherine M Bollard Research Topics

Disease

78	Neoplasms (Cancer) 01/2022 - 03/2002
29	Lymphoma (Lymphomas) 01/2022 - 09/2005
27	Infections 10/2022 - 03/2006
27	Virus Diseases (Viral Diseases) 10/2022 - 10/2002
22	Graft vs Host Disease (Graft-Versus-Host Disease) 10/2022 - 12/2006
18	Hodgkin Disease (Hodgkin's Disease) 01/2022 - 05/2002
14	Hematologic Neoplasms (Hematological Malignancy) 09/2022 - 12/2014
11	Leukemia 01/2022 - 09/2010
10	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2020 - 06/2008
8	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 09/2022 - 11/2008
6	Inflammation (Inflammations) 01/2021 - 07/2009
6	Melanoma (Melanoma, Malignant) 01/2021 - 11/2010
5	COVID-19 09/2022 - 01/2020
5	B-Cell Lymphoma (Lymphoma, B Cell) 11/2021 - 05/2011
5	Primary Immunodeficiency Diseases 01/2020 - 01/2017
5	Epstein-Barr Virus Infections 01/2017 - 09/2008
4	Cytokine Release Syndrome 09/2022 - 05/2018
4	Testicular Neoplasms (Testicular Cancer) 12/2021 - 10/2011
4	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 11/2018 - 01/2008
3	Nasopharyngeal Carcinoma 05/2014 - 01/2003
2	Disease Progression 01/2022 - 01/2021
2	Hematologic Diseases (Blood Diseases) 01/2022 - 01/2018
2	Synovial Sarcoma (Synovioma) 12/2021 - 12/2011
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2021 - 09/2010
2	Brain Neoplasms (Brain Tumor) 11/2021 - 01/2019
2	Adenoviridae Infections (Adenovirus Infections) 01/2021 - 03/2006
2	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 01/2021 - 09/2017
2	Paramyxoviridae Infections (Parainfluenza) 01/2020 - 12/2016
2	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 01/2020 - 01/2018
2	Neuroblastoma 01/2019 - 01/2017
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2022
1	Respiratory Insufficiency (Respiratory Failure) 01/2022
1	Viremia 12/2020

Drug/Important Bio-Agent (IBA)

42	AntigensIBA 01/2022 - 01/2003
15	Chimeric Antigen ReceptorsIBA 09/2022 - 05/2011
13	Membrane Proteins (Integral Membrane Proteins)IBA 12/2020 - 12/2004
10	Antiviral Agents (Antivirals)IBA 10/2022 - 04/2010
10	CytokinesIBA 01/2021 - 05/2002
9	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2003
9	EpitopesIBA 12/2021 - 09/2005
8	Viral AntigensIBA 09/2017 - 03/2002
7	Neoplasm Antigens (Tumor Antigens)IBA 10/2018 - 02/2004
5	SurvivinIBA 01/2022 - 10/2011
5	Transforming Growth Factor beta (TGF-beta)IBA 01/2022 - 05/2002
5	Peptides (Polypeptides)IBA 11/2021 - 04/2009
5	HLA Antigens (Human Leukocyte Antigens)IBA 01/2016 - 04/2009
4	DNA (Deoxyribonucleic Acid)IBA 10/2022 - 06/2011
4	tisagenlecleucelIBA 09/2022 - 01/2019
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2021 - 12/2017
4	Transforming Growth Factors (Transforming Growth Factor)IBA 10/2018 - 05/2006
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2021
3	Rituximab (Mabthera)FDA Link 11/2021 - 12/2017
3	VaccinesIBA 01/2020 - 01/2008
3	Pharmaceutical PreparationsIBA 12/2019 - 01/2019
3	Interleukin-2 (IL2)IBA 07/2014 - 02/2004
2	InterferonsIBA 12/2021 - 10/2011
2	Prednisone (Sone)FDA LinkGeneric 11/2021 - 12/2017
2	Vincristine (Oncovin)FDA LinkGeneric 11/2021 - 12/2017
2	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2021 - 12/2017
2	Etoposide (VP 16)FDA LinkGeneric 11/2021 - 12/2017
2	RNA (Ribonucleic Acid)IBA 11/2021 - 06/2011
2	SteroidsIBA 01/2021 - 01/2019
2	AntibodiesIBA 01/2021 - 09/2019
2	ChemokinesIBA 12/2020 - 10/2011
2	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2019 - 10/2015
2	Monoclonal AntibodiesIBA 09/2017 - 11/2009
2	Interleukin-13IBA 10/2011 - 02/2004
2	Interleukin-12 (IL 12)IBA 10/2011 - 02/2004
2	Chemokine CCL17IBA 10/2011 - 02/2004
2	Viral ProteinsIBA 10/2007 - 09/2005
1	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2022
1	blinatumomabIBA 09/2022
1	Bortezomib (Velcade)FDA Link 01/2022
1	NivolumabIBA 01/2022
1	Proteasome InhibitorsIBA 01/2022
1	Phosphotransferases (Kinase)IBA 01/2021
1	LigandsIBA 01/2021
1	Brentuximab VedotinIBA 01/2021
1	CalcineurinIBA 01/2021
1	ProteomeIBA 12/2020
1	nelarabine (506U78)FDA Link 10/2020
1	Methotrexate (Mexate)FDA LinkGeneric 10/2020
1	pegaspargase (Oncaspar)FDA Link 10/2020
1	Indocyanine Green (Cardio-Green)FDA LinkGeneric 01/2020
1	4- ((1- butyl- 3- phenylureido)methyl)- N- hydroxybenzamideIBA 01/2020

Therapy/Procedure

74	Therapeutics 10/2022 - 10/2002
48	Immunotherapy 01/2022 - 10/2002
29	Hematopoietic Stem Cell Transplantation 10/2022 - 03/2006
24	Transplantation 01/2022 - 11/2008
17	Drug Therapy (Chemotherapy) 01/2022 - 05/2010
17	Stem Cell Transplantation 01/2021 - 03/2004
7	Bone Marrow Transplantation (Transplantation, Bone Marrow) 12/2020 - 05/2006
6	Cell Transplantation 01/2022 - 12/2015
6	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2021 - 06/2015
4	Art Therapy 12/2020 - 01/2016
2	Homologous Transplantation 10/2022 - 08/2013
2	Salvage Therapy 01/2022 - 01/2021
2	Photothermal Therapy 01/2020 - 01/2017
2	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 07/2016 - 09/2010
1	Radiotherapy 11/2021